Crystalline forms
US6696479B2 · kind B2 · utility
10Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2002 |
| Grant date | Feb 24, 2004 |
| Priority date | — |
| Expiry date | Jul 30, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel crystalline forms of Fluvastatin sodium hydrates were found, referred to hereinafter as polymorphic Forms C, D, E and F. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms, a process for the preparation of highly crystalline Fluvastatin sodium Form A, and pharmaceutical compositions comprising the crystalline forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.